Postoperative Continuous Infusion of Dexmedetomidine Did Not Improve Recovery of Gastrointestinal Function in Laparoscopic Colorectal Surgery: A Randomized Clinical Trial

Objectives: To explore the effects of postoperative infusion of dexmedetomidine on the recovery of gastrointestinal function among patients undergoing laparoscopic colorectal surgery.Methods: 130 participants aged 18 to 75 years who were scheduled to receive laparoscopic colorectal surgery were enrolled.Dexmedetomidine infusion was conducted as a loading dose of 0.5 g/kg over 15 minutes before skin scuffing followed by a dose of 0.05 g/kg per hour at the end of surgery lasting 48h in dexmedetomidine group, while patients in the control group only received loading dose of 0.5 g/kg.The primary outcome was time to first flatus.Secondary outcomes were postoperative gastrointestinal function measured by the I-FEED (intake, feeling nauseated, emesis, physical examination, and duration of symptoms) scoring system, time to first oral feeding, incidence of delirium, pain scores, sleep quality, postoperative anxiety states, postoperative nausea and vomiting and length of stay in hospital.Plasma samples were collected to test concentrations of C-reactive protein.Results: Among 130 patients enrolled, 60 were randomized to receive intraoperative dexmedetomidine, and 60 were randomized to receive placebo.There was no significant difference in time to first flatus (median, 59 hours [IQR, 50.5-66.9hours] vs 63.5 hours [49.3-81.6 hours], respectively; P= 0.15), time to first feces (median, 86 hours [IQR, 68-115 hours] vs 70.3 hours [IQR, 56.1-95.5 hours]; P =0.43), and time to first oral feeding (median, 77.5 hours [68.1-86.7]vs 79.3 [IQR, (67.6-100.4)] P =0 .29).Postoperative gastrointestinal function (measured by the I-FEED score) and delirium incidence were similar in the dexmedetomidine and control group.Patients in the dexmedetomidine group had longer total sleep time and higher sleep efficiency than those in the control group.Conclusion: Postoperative continuous infusion of dexmedetomidine could improve the quality of sleep after laparoscopic colorectal surgery.However, postoperative dexmedetomidine infusing continuously after laparoscopic colorectal surgery did not improve recovery of gastrointestinal function.

Authors

Publication Details

Journal
Research Review
Published
2025-08-04
DOI
https://doi.org/10.52845/cs/2025-5-4-1
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Postoperative Continuous Infusion of Dexmedetomidine Did Not Improve Recovery of Gastrointestinal Function in Laparoscopic Colorectal Surgery: A Randomized Clinical Trial

Fei Wang
Research Review
Anesthesia and Sedative Agents
article

Postoperative Continuous Infusion of Dexmedetomidine Did Not Improve Recovery of Gastrointestinal Function in Laparoscopic Colorectal Surgery: A Randomized Clinical Trial

Fei Wang
article en

Abstract

Objectives: To explore the effects of postoperative infusion of dexmedetomidine on the recovery of gastrointestinal function among patients undergoing laparoscopic colorectal surgery.Methods: 130 participants aged 18 to 75 years who were scheduled to receive laparoscopic colorectal surgery were enrolled.Dexmedetomidine infusion was conducted as a loading dose of 0.5 g/kg over 15 minutes before skin scuffing followed by a dose of 0.05 g/kg per hour at the end of surgery lasting 48h in dexmedetomidine group, while patients in the control group only received loading dose of 0.5 g/kg.The primary outcome was time to first flatus.Secondary outcomes were postoperative gastrointestinal function measured by the I-FEED (intake, feeling nauseated, emesis, physical examination, and duration of symptoms) scoring system, time to first oral feeding, incidence of delirium, pain scores, sleep quality, postoperative anxiety states, postoperative nausea and vomiting and length of stay in hospital.Plasma samples were collected to test concentrations of C-reactive protein.Results: Among 130 patients enrolled, 60 were randomized to receive intraoperative dexmedetomidine, and 60 were randomized to receive placebo.There was no significant difference in time to first flatus (median, 59 hours [IQR, 50.5-66.9hours] vs 63.5 hours [49.3-81.6 hours], respectively; P= 0.15), time to first feces (median, 86 hours [IQR, 68-115 hours] vs 70.3 hours [IQR, 56.1-95.5 hours]; P =0.43), and time to first oral feeding (median, 77.5 hours [68.1-86.7]vs 79.3 [IQR, (67.6-100.4)] P =0 .29).Postoperative gastrointestinal function (measured by the I-FEED score) and delirium incidence were similar in the dexmedetomidine and control group.Patients in the dexmedetomidine group had longer total sleep time and higher sleep efficiency than those in the control group.Conclusion: Postoperative continuous infusion of dexmedetomidine could improve the quality of sleep after laparoscopic colorectal surgery.However, postoperative dexmedetomidine infusing continuously after laparoscopic colorectal surgery did not improve recovery of gastrointestinal function.

Research Review
Openalex Percentile: Top 68%
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Postoperative Continuous Infusion of Dexmedetomidine Did Not Improve Recovery of Gastrointestinal Function in Laparoscopic Colorectal Surgery: A Randomized Clinical Trial — Fei Wang · Research Review (2025) | TGRS Research Map | TGRS